ISSN: 1943-4588

Journal Guideline

Current Breast Cancer Reports Q3 Unclaimed

Current Science, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Breast Cancer Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of breast cancer. It has an SJR impact factor of 0,351.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Oncology (Q3)

Price

2590 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,351

SJR Impact factor

24

H Index

44

Total Docs (Last Year)

122

Total Docs (3 years)

2734

Total Refs

138

Total Cites (3 years)

121

Citable Docs (3 years)

1.1

Cites/Doc (2 years)

62.14

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer Management and Research Q3
Journal of Breast Cancer Q3
Breast Cancer: Basic and Clinical Research Q3
Oncology Letters Q3
Clinical Medicine Insights: Oncology Q3

Compare this journals

Aims and Scope

Best articles by citations

State of the Art in Breast Reconstruction

Who Benefits from Nodal Field Irradiation?

Preoperative Radiotherapy Trials to Facilitate Immediate Breast Reconstruction after Mastectomy

State of the Art in Imaging and Chemoprevention for High-Risk Patients

Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents

Integrative Review of the Supportive Care Needs of Asian and Caucasian Women with Breast Cancer

Surgical Management of Hereditary Breast Cancer

Increasing contralateral mastectomy use at diagnosis: Surgical prevention of contralateral breast cancer

Therapeutic strategies to eliminate breast cancer stem cells

The Role of Deep Learning in Breast Screening

Molecular classes of breast cancer and their clinical relevance

Incorporating Agents that Target HER2 in the Neoadjuvant Setting

SHOW MORE ARTICLES

Emerging Prognostic and Predictive Biomarkers for Triple Negative Breast Cancer

Advances in clinical trial designs for predictive biomarker discovery and validation

Optimal Margin Width in Breast Conservation Therapy: a Review of the Current Guidelines and Literature

Breast Atypia as a Biomarker of Risk

Early Diagnosis of Breast Cancer in the Absence of Population-Based Mammographic Screening in Asia

Patient Selection and Technical Considerations in Nipple-Sparing and Areola-Sparing Mastectomy

Targeted Therapies for HER2 Breast Cancer: A View of the Landscape

Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer?

Eliminating Surgery in Early-Stage Breast Cancer: Pipe-Dream or Worthy Consideration in Selected Patients?

Impact of Breast Cancer Subtypes on Local-Regional Outcomes

Lymphedema: How Do We Diagnose and Reduce the Risk of This Dreaded Complication of Breast Cancer Treatment?

The Genetic Information Nondiscrimination Act of 2008 (GINA) and the Patient Protection and Affordable Care Act of 2010 (PPACA): What They Mean for Breast Cancer Patients and Their Families